Enterprise Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Enterprise Bank & Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$222K	Hold	4,806	–	–	0.08%	127
2025 Q1	$293K	Buy	4,806 +485	+11%	+$28.3K	0.11%	107
2024 Q4	$244K	Buy	4,321 +217	+5%	+$12.1K	0.08%	117
2024 Q3	$212K	Buy	+4,104	New	+$193K	0.07%	122
2024 Q2	–	Sell	-4,316	Closed	-$234K	–	122
2024 Q1	$234K	Sell	4,316 -750	-15%	-$38.2K	0.08%	115
2023 Q4	$260K	Buy	5,066 +684	+16%	+$35.9K	0.09%	107
2023 Q3	$254K	Buy	4,382 +364	+9%	+$22.3K	0.1%	95
2023 Q2	$257K	Buy	+4,018	New	+$269K	0.1%	100
2021 Q2	–	Sell	-3,710	Closed	-$234K	–	99
2021 Q1	$234K	Sell	3,710 -670	-15%	-$41.7K	0.1%	82
2020 Q4	$272K	Sell	4,380 -150	-3%	-$9.22K	0.12%	82
2020 Q3	$273K	Sell	4,530 -1,221	-21%	-$73.5K	0.13%	74
2020 Q2	$338K	Buy	5,751 +210	+4%	+$12.6K	0.17%	67
2020 Q1	$309K	Sell	5,541 -399	-7%	-$24.4K	0.18%	67
2019 Q4	$381K	Buy	5,940 +1,300	+28%	+$74.5K	0.17%	72
2019 Q3	$235K	Hold	4,640	–	–	0.11%	78
2019 Q2	$210K	Sell	4,640 -565	-11%	-$26.3K	0.11%	83
2019 Q1	$248K	Buy	+5,205	New	+$259K	0.1%	89

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Enterprise Bank & Trust's BMY Position: Q2 2025 in Review

Enterprise Bank & Trust held its Bristol-Myers Squibb (BMY) position steady in Q2 2025 at 4,806 shares worth $222K. The position accounts for 0.08% of the portfolio, ranked #127.

Enterprise Bank & Trust first reported a position in BMY in Q1 2019 and has held it in 17 quarters since. The position peaked at $381K in Q4 2019. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Enterprise Bank & Trust held 4,806 shares of Bristol-Myers Squibb worth $222K as of Q2 2025.
Enterprise Bank & Trust left its Bristol-Myers Squibb share count unchanged in Q2 2025.
Bristol-Myers Squibb made up 0.08% of Enterprise Bank & Trust's portfolio in Q2 2025, its #127 holding.
Enterprise Bank & Trust first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 17 quarters since.
Enterprise Bank & Trust's Bristol-Myers Squibb position peaked at $381K in Q4 2019.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Enterprise Bank & Trust's 13F filing for Q2 2025, filed 7 Jul 2025.